{"ticker": {"uuid": "fb1552bd-ed4a-447a-beb8-de390215801e", "symbol": "CAI", "name": "Caris Life Sciences, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Caris Life Sciences, Inc. - Common Stock (CAI) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE96aTFlN0x1LXFPOUtDbHI0MGR0bmR3dVp1UE1fWGhjZGk0Rk84Q0VnbDN0ZVpEcDFaUUplLU1ZeGUyVlZTOXlTNXh3WVBIOVI4WURIcmZxbW4?oc=5", "source_name": "FinancialContent", "published_at": "2026-07-23T00:44:00+00:00", "published_display": "23 Jul 2026 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/biomarker-collaboration-licensing-deals-report-162800336.html", "source_name": "GlobeNewswire", "published_at": "2026-07-21T16:28:00+00:00", "published_display": "21 Jul 2026 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection (NASDAQ:CAI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPcmFJU0xwa0Q4QWFkQjN3NzgyR3pMRTV2UUhGOFBxUnRZMlc5TzB0dTBRZFhuVVV2T3VlTWEzUFRWbDR5SFE2TUl6bVZFc0hWOEVIZDBwR2d1YkRJcE9YY2R4c0dOSmdtVmdHbTRQX2tSUVVnbmdwanhid0tnellWazhQVmcybV9fRXVLYk14WERVcnRCWVVrWDZINUpJT0Fmc3BJblZoRjV2OE0wODBnSmJR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-21T09:29:37+00:00", "published_display": "21 Jul 2026 09:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNd3VkT25zNzRGYVdWeXJCZC0xWXJCbXNyMjNUREdmOVBHeUk3WnZjaUNSRWpUVkxxcTBCWktmTl9CdmIxR1c3aUpJRkpHdGZMNUJOcllwckEyeTY4Y0V3dmNjSHc4NjlMNHd6ZlNobTJvdk9Ud1B6NFpZV3Z0Yl9ic0ZhY3c3dllMMkFaMHA5bGc1b1JGZFBReS1R?oc=5", "source_name": "Market source", "published_at": "2026-07-17T20:09:17+00:00", "published_display": "17 Jul 2026 20:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOS050VHA5bklaNkM1bWxTZTVyU3hjTmppd19Td0NDRHVIUXlGT1BEMkoxY0otTUJ3Ylo1N1pubDg2Z2R5U1oyb0Y1dEhEQVh4WTV5aTh1a3JNcG43RTZzVld1UUFBMjJPRUY4WEpYLWR0X2VqOUttSE4wMVoxNUJqYUpRSUlWZVFBbHV3S29aTVdGQVBSUVNZeg?oc=5", "source_name": "Market source", "published_at": "2026-07-17T14:10:31+00:00", "published_display": "17 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T12:35:12+00:00", "published_display": "17 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNQXZBYXdOMWxRNmRtU044Wk5ubUk0SzB5LW9RLW9zOW9Ob0h4dnFoRWpTd0oweTZMUXMwOG9keXdVZmExTWs3SHZPVjNFYzlQVS1GRE95QzRoUm01ZTlPbWtWa1Y2aFQ4SlIzMGk0YzhQTTlwdzhEelpKQThhd2pRX19KbmQ3WnJYYUdHT3pOSkMtTkw5S3ROVg?oc=5", "source_name": "Market source", "published_at": "2026-07-17T11:12:52+00:00", "published_display": "17 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-report-second-123000452.html", "source_name": "PR Newswire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Sets 3:30 p.m. CT Webcast for Aug. 5", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOSXIyODN5YmgwSXg0OXFEY3NvYkUzYVdUUW5jc1gyWTlmTGtrdTBUSlBvODRicVJjU3djU3plSjR0V01PTlhab1F0RGppcklSejFfSWFIa1l2SGVteTlNV2hrX2p4T2FQazM5VDE3V3U3c1NTWEdMZmdxV1hwbkswckZGNXk5dUEwTWc5dUJPSUNaN1NHNTVta1dad01OSHl3NGhtTVgyR3hVMk8xRll5VXY4bmFTRGhlSGU0aGp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-expands-precision-123000480.html", "source_name": "PR Newswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences, Inc. (CAI) Receives a Buy from Bank of America Securities", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQZC16d2tuQ1ZrV2JvcHBwaE9SOUhmWnBKM3pKdTNLVnE4TTdrdTQ3RG9PY0lFLXJ4clFYMXVXZk1wYm0wdzl3QVNMMWJjNGNBUTc3dTRSdzFCd2hSckpZbDFOTGlFS2FWV0paTXltaExBemNwa0VCRF9vWVNacGFtWVdkYmE3MHNtTVJ4ZHEtRjVXWWZQUzdQelFmd0JLeXYwZWJDVkxCWENzMnA5OUo3QWtKaDZXUGpzV3hZWUJaTjdJbGpuV0RzdVlyRGVWVDBmU2xRU0lVZ2pWckNUbC1uQURZS0xaZ1FCTDd3RVQxaw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-14T10:26:00+00:00", "published_display": "14 Jul 2026 10:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA Adjusts Price Target on Caris Life Sciences to $23 From $28", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bofa-adjusts-price-target-caris-153602935.html", "source_name": "MT Newswires", "published_at": "2026-07-13T15:36:02+00:00", "published_display": "13 Jul 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Caris Life Sciences, Inc. Insider Trading Activity", "summary": "Caris Life Sciences director Jon Halbert reported an open-market purchase of 68,000 shares of Common Stock on May 15, 2026, at a weighted average price of $14.56 per share. This transaction was conducted through LAH Investments, Ltd., increasing its indirect holdings to 704,598 s", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-a224c1601370.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:39:18", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock", "summary": "Caris Life Sciences (NASDAQ:CAI) Director Jon Halbert purchased 68,000 shares of the company's stock for $990,080 on May 15th, increasing his total ownership to 704,598 shares. This insider buying comes as the company also announced a $100 million share repurchase program, sugges", "url": "https://www.marketbeat.com/instant-alerts/insider-buying-caris-life-sciences-nasdaqcai-director-acquires-99008000-in-stock-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T15:39:18", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Form 4 Caris Life Sciences Inc For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Caris Life Sciences Inc., dated July 13. Form 4s disclose transactions made by company insiders, and are routinely published by Investing.com. The information provided is brief, stating only the company name and filing date.", "url": "https://ca.investing.com/news/stock-market-news/form-4-caris-life-sciences-inc-for-13-july-93CH-4730876", "source_name": "Investing.com Canada", "published_at": "2026-07-13T07:30:00", "published_display": "13 Jul 2026 07:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Recommendation of \"Hold\" from Brokerages", "summary": "Caris Life Sciences, Inc. (NASDAQ:CAI) has received a consensus \"Hold\" rating from eleven brokerages, with an average 12-month price target of $26.11. Insider activity shows Director Jeff L. Vacirca increasing his stake by 166.75%, and the company's board has authorized a $100 mi", "url": "https://www.marketbeat.com/instant-alerts/caris-life-sciences-inc-nasdaqcai-receives-consensus-recommendation-of-hold-from-brokerages-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-11T02:11:52", "published_display": "11 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-cai-launches-135915925.html", "source_name": "Insider Monkey", "published_at": "2026-07-10T13:59:15+00:00", "published_display": "10 Jul 2026 13:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breakeven Is Near for Caris Life Sciences, Inc. (NASDAQ:CAI)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-launches-caris-123000122.html", "source_name": "PR Newswire", "published_at": "2026-07-01T12:30:00+00:00", "published_display": "01 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQVnlONnc4bklGbTNMOUs0bVl4Um50VWNZeGtGLUplYmNwLUJkcWVWaExDbnpibHRPLW9UU1ZrM0tTN2xiTFd4M2xrMXdnX3E3eGZHZEt5S091QzBjUkMzamtoWks5cG53cDdzX0VHbTA2MlJuaDh6bkpIVWdXQVRYVWFWYkNsVW1xRTM0QlVJWGxTUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Caris Life Sciences Stock Could Be the Most Mispriced Oncology Platform Trading Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNWp1cldjeHVZUEVxeFFEUmpHVlFja245a2hGamlwWjktQUg3NWlGVWg2NHRfTDRYQ29iODZvZC1VQk1HUTMzdmRwVXhxb1lLZDhMT0JQSVh4N2lIUFZCb1YwdS1LWE9ESFgyYUpSc3BKWVFjamVGcUtZVFhDM0xtRkxPV3JNUmlqbHdQNFlDbVlWX1F1aHlmcl9waG93blpvNDhNWDFKRldEN1ZJa2p4bnoyRzR3MG5VQWdN?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYThaOGdncWV5VHB1QXQzMGVtU1ZjQkdzQnhhZVlCbDFHbnYzX215SkdBREdLNm5mUW9KYUc5dldhcWlLY2llQ1l6OFkzTHU1aHNDRXhhSGU0MkR1MFBHQ0ttdnhyN2RmTWhLNFViNmM5Z2hfc1NSa3ZGWkFTODloMHBjLVVJZU55cEJDOENsdUVkZUdiaGpF?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Announces $100M Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUFRBRG42V1l6djNYTEgwSTNYSURSU2w0MFItRS1sdzNxMGEyOXktbWZJdWtGZDRBa28yR05YTkk3MW1jRkdOSHdGUnBwS2ZQcXp6OFFsaEdydHlMMnRLSGZDaXp5RHNLY3lFYU9WY0NvR3FmMi1uM2hmNzdrRF9sckl6bnpCSEEtTlNwYy1IYWJodndMVDZjZ1Njdnl4LXc?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Announces Dual Listing on NYSE Texas", "summary": "Caris Life Sciences (NASDAQ: CAI) announced a dual listing of its common stock on NYSE Texas, effective June 17, 2026. This move expands its presence in public markets while retaining its primary listing on NASDAQ. The dual listing is intended to provide additional exposure to in", "url": "https://www.morningstar.com/news/pr-newswire/20260616da84386/caris-life-sciences-announces-dual-listing-on-nyse-texas", "source_name": "Morningstar", "published_at": "2026-06-17T05:10:47", "published_display": "17 Jun 2026 05:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI precision-medicine company Caris adds NYSE Texas listing", "summary": "Caris Life Sciences, a patient-centric AI TechBio and precision medicine company, announced a dual listing of its common stock on NYSE Texas, effective June 17, 2026. Shares will continue to trade on NASDAQ under the CAI ticker while also listing on NYSE Texas, aiming for increas", "url": "https://www.stocktitan.net/news/CAI/caris-life-sciences-announces-dual-listing-on-nyse-apdm69r81q7b.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:39:59", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Stock\u2019s Gross Margin Story: From 38% to 65% in Seven Quarters and What Comes Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPYzA2RlZNME5lVFRCSVBiT2RLaW85NnJkc0N0Tk1DZjhmNXVKdGIwRnhXVklmdExQZXIxNjJnY3FlR0QzTEhNa2FJSnN2azJ2OFBST1VoSlBFT1VLQV9TSDk3eW1xY1Q1ZEQ1ejQxWEZROUZLT1RGMnZwOXhTSmRjb21jQ04taUZfWjR0UmhRc0JhWnZBb3RNSDNYeVNaZS1MUGxWZDllWWtlQy1ucUxEMExFUWRDR28taG93bnBQN1I?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Announces Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUW9LYWNXU3MzMDNyU0tTaEhmWWc4RHJCZFZiN0x6aGpkamZvbDRWTVlUTXVUZE1BS0pyaEY3ZDBtR3pwQ01jUFhwOHpZMU5RM25LQVJmOTJ4OWN0bFB3S0dIS2dUd2g1OEJjcy1PbGQ4Ri1oMm00eTJtYlpqczVXUzRRUWswRUFibTZDZEZQM1FEVHpZclJTZWNFei1tQmxZTF9CenZRRnMwLXdFbXZF?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director takes Caris Life Sciences (CAI) 2026 board fees in stock", "summary": "Caris Life Sciences director Jonathan Kenneth Charles Knowles received 1,600 shares of common stock on May 29, 2026, as compensation for his 2026 board retainer fees. These shares were granted in lieu of cash, based on a ten-day volume weighted average price calculation of $15.62", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-3865b8a3748a.html", "source_name": "Stock Titan", "published_at": "2026-06-02T22:40:55", "published_display": "02 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing", "summary": "Caris Life Sciences has launched its \"Behind the Diagnosis\" campaign to highlight how its comprehensive genomic testing and AI-powered precision medicine have transformed patient care. The inaugural story features Erika Rios, whose initial diagnosis of stage 4 metastatic breast c", "url": "https://www.biospace.com/press-releases/caris-life-sciences-launches-behind-the-diagnosis-campaign-spotlighting-patient-lives-transformed-by-caris-comprehensive-genomic-testing", "source_name": "BioSpace", "published_at": "2026-06-01T22:09:36", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life (CAI) director granted 1,600 shares for 2026 board fees", "summary": "Caris Life Sciences director George Poste received 1,600 shares of common stock as compensation for his 2026 board retainer fees, granted at a reference price of $15.62 per share. This equity award, given in lieu of cash, brings his direct holdings to 17,729 shares. Additionally,", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-12d5f62338dd.html", "source_name": "Stock Titan", "published_at": "2026-05-31T17:39:45", "published_display": "31 May 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CAI - Caris Life Sciences Inc Stock Price and Quote", "summary": "This article provides a detailed stock quote and financial data for Caris Life Sciences Inc. (CAI), including its latest closing price, market capitalization, key financial ratios, and analyst ratings. It also lists recent news announcements and insider trading activities related", "url": "https://finviz.com/stock?t=CAI", "source_name": "Finviz", "published_at": "2026-05-30T09:39:28", "published_display": "30 May 2026 09:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "You\u2019ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has \u2013 and He Likes What He Sees.", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQQWNpSkY3NFFkbWRXdS1EWDJFX1BVemM5YjU2SUhQRXZtbTduLWZyNF9HNThvUXc2ZzQ5b3JTYzBLQWlqMnVYY0cyS2x1S3ItRHJ0alVXdzl0ek9LSzVURjllZlVFeUViUDFBLVVfeHpLcEJuMnVGbnNkWHBtbDcwbl9TMzFpb3NHbjRwQ2RJR05JRnNsR09r?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence", "summary": "Caris Life Sciences, along with the Caris Precision Oncology Alliance and over 60 collaborators, will present 32 studies at the 2026 ASCO Annual Meeting. These studies focus on multi-omic biomarker research and real-world data to enhance understanding of tumor biology and guide p", "url": "https://www.morningstar.com/news/pr-newswire/20260522da65612/caris-life-sciences-to-present-32-studies-at-asco-2026-highlighting-advances-in-multi-omic-biomarker-research-and-real-world-evidence", "source_name": "Morningstar", "published_at": "2026-05-20T05:09:10", "published_display": "20 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) exec has 6,047 shares withheld for RSU taxes", "summary": "Caris Life Sciences executive John Russel Denton had 6,047 shares of common stock withheld at $15.25 per share to cover RSU taxes on May 15, 2026. This transaction is categorized as a non-market tax-withholding disposition, not an open-market sale. Following this activity, Denton", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-b9ca07940683.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) logs RSU tax share withholding", "summary": "Caris Life Sciences president David Baxley Spetzler reported a routine tax-withholding disposition for 13,856 shares of common stock at $15.25 per share, covering taxes related to vested Restricted Stock Units (RSUs). Following this transaction, Spetzler directly owns 530,083 sha", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-0c8a048c9191.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) director logs RSU tax withholding and large indirect stake", "summary": "Caris Life Sciences director David D. Halbert reported a routine disposition of 40,712 shares of Common Stock to cover tax obligations related to the vesting of restricted stock units (RSUs) at a price of $15.25 per share. After this transaction, Mr. Halbert directly holds 2,574,", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-6b3b29b324c8.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%", "summary": "Caris Life Sciences is expanding its precision oncology platform, product pipeline, and biopharma partnerships after its IPO last June, seeing significant growth potential in the oncology market, which is currently only about 35% penetrated. The company reported a 79% year-over-y", "url": "https://www.marketbeat.com/instant-alerts/caris-life-sciences-eyes-bigger-oncology-market-after-ipo-as-revenue-jumps-79-2026-05-13/", "source_name": "MarketBeat", "published_at": "2026-05-17T20:10:29", "published_display": "17 May 2026 20:10", "sentiment": "positive", "sentiment_pct": 93, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Druckenmiller's Duquesne Office Invests in Broadcom and Caris Life Sciences", "summary": "Duquesne Family Office, led by Stanley Druckenmiller, made significant investment shifts in Q1 2026, acquiring shares in Broadcom (AVGO) and Caris Life Sciences (CAI) while exiting positions in Alphabet Class A and Cogent Biosciences. The firm also increased its holdings in STMic", "url": "https://intellectia.ai/news/stock/druckenmillers-duquesne-office-invests-in-broadcom-and-caris-life-sciences", "source_name": "Intellectia AI", "published_at": "2026-05-15T21:09:28", "published_display": "15 May 2026 21:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)", "summary": "Two healthcare stocks, Crispr Therapeutics AG (CRSP) and Caris Life Sciences, Inc. (CAI), have received bullish sentiments from analysts. Crispr Therapeutics AG was maintained with a Buy rating and an $83 price target by Bank of America Securities, with a Moderate Buy consensus a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CRSP-Q/pressreleases/1951199/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai/", "source_name": "The Globe and Mail", "published_at": "2026-05-15T08:08:47", "published_display": "15 May 2026 08:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings call transcript: Caris Life Sciences Q1 2026 sees robust growth but stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPWkNMeVpkTk40eU1IQUpWWXA3V3cwc2JpNUlKLUVfUngzMWpOeVpDQ2ZtMkdHVEZ3ZHh1V20zU1paX19hRHJhSXdCUEV3aTM2SVE5VTR6QTIzTTR2TThyNVZpZzRXMEgzbU02RUlHVUotSExodTRQbnlLZGl0U1lHcDFQWExNeWVNd1dEQ3B4dUxZTHJZNDcxSk9RUll3d2F2c2dMMFhJOVhXMzE1blBHUjJuUUxrbW5qMEVsV2tRS09HY3E0MkJwX2JBUzNXUndGLTByWG5PQk9FZw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Caris Life Sciences (CAI) Valuation After Recent Growth, Product Launches And Clinical Data Advances", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "[SCHEDULE 13G/A] Caris Life Sciences, Inc. Amended Passive Investment Disclosure", "summary": "TSSP Sub-Fund HoldCo, LLC and Alan Waxman have jointly filed an amended Schedule 13G/A, disclosing their beneficial ownership stakes in CARIS Life Sciences, Inc. As of March 31, 2026, TSSP Sub-Fund HoldCo holds 4.8% of outstanding common stock, while Alan Waxman holds 5.1%, both ", "url": "https://www.stocktitan.net/sec-filings/CAI/schedule-13g-a-caris-life-sciences-inc-amended-passive-investment-dis-bb1351896ef5.html", "source_name": "Stock Titan", "published_at": "2026-05-12T21:39:43", "published_display": "12 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J.H. Whitney reports 18.26M shares of Caris Life Sciences (CAI)", "summary": "J.H. Whitney VI, L.P. and its affiliated reporting persons have disclosed a beneficial ownership of 18,256,615 shares of Caris Life Sciences, Inc. (CAI) common stock, which represents 6.5% of the class. This information was reported in an amended Schedule 13G filing. The reportin", "url": "https://www.stocktitan.net/sec-filings/CAI/schedule-13g-a-caris-life-sciences-inc-amended-passive-investment-dis-c8c3cbaae8e0.html", "source_name": "Stock Titan", "published_at": "2026-05-12T14:39:43", "published_display": "12 May 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director buys 31K Caris Life Sciences (CAI) shares around $16.15", "summary": "Caris Life Sciences director Jeff L. Vacirca purchased 31,050 shares of Common Stock in an open-market transaction at a weighted average price of $16.149 per share. This purchase increased his direct ownership to 49,671 shares. The transaction is viewed positively and was reporte", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-95e3dcb195b4.html", "source_name": "Stock Titan", "published_at": "2026-05-12T12:32:41", "published_display": "12 May 2026 12:32", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Caris Life Sciences (CAI) Turns Q4 Profit After US$517 Million Quarterly Loss Testing Bullish Thesis", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging revenue lifts Caris Life Sciences (CAI) toward profit in Q1 2026", "summary": "Caris Life Sciences (CAI) reported strong Q1 2026 growth, with total revenue nearly doubling to $216.174 million, primarily driven by molecular profiling services. The company achieved income from operations of $5.282 million and narrowed its net loss to $0.510 million, indicatin", "url": "https://www.stocktitan.net/sec-filings/CAI/10-q-caris-life-sciences-inc-quarterly-earnings-report-1c89c6ad3f63.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:09:42", "published_display": "08 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood\u2011Based Testing Authorization", "summary": "Caris Life Sciences has submitted an application to the New York State Department of Health (NYSDOH) for authorization of its Caris Assure blood-based molecular profiling test. This test, which analyzes whole exome and transcriptome, is designed to support comprehensive biomarker", "url": "https://www.morningstar.com/news/pr-newswire/20260508da55078/caris-life-sciences-submits-application-to-new-york-state-department-of-health-for-caris-assure-bloodbased-testing-authorization", "source_name": "Morningstar", "published_at": "2026-05-08T20:05:00", "published_display": "08 May 2026 20:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Caris Life Sciences (CAI) Valuation As Shares Trade Below Narrative Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONWV6MzBudExCa2RRdkFxTUFoeDdLUXRDZUdYMXRYSE1CNFBqS0d5TVQ0VmZOWkpMZFRjTVFhN3pTT195OUVrcEhmaEVBVGN6Y2E0dUF6WE15b295S19lV3FQVGFSOEJrRFpsTzdkcjhqVGNIN2dJdGd5VUpkbzYwaUxaV1RKVjEzcEx4cnFXSkZuTXhubC1vbktWeHh3ekU?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Caris Life Sciences (CAI) After 26.5% Year To Date Decline?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMHRLNkhFTk9FcGtHMG9lM0ZIT1RoWkpVN2o5cVBBNXREYmNiQUxwSDUyV3BGS3l1OTZaMFlvOUxRdDA3b291SmFMVnhNSjN5QlZ3ODFYN1UtZGpQYjBETnZJUW1qVTVoaUZFUEdQdWJ3TGpPRnB6dlhlMmJOc3N5Q1ZfWDBoV1JxQThQMVZYc2lfbzN5eHlEV0FVRXNGT2xaVnZwRXBlY2ptYThvNTB4U2JDa25tUzFYMk10Mg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Caris Life Sciences, Inc. - Common Stock (CAI) Stock Price, News, Quote & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE96aTFlN0x1LXFPOUtDbHI0MGR0bmR3dVp1UE1fWGhjZGk0Rk84Q0VnbDN0ZVpEcDFaUUplLU1ZeGUyVlZTOXlTNXh3WVBIOVI4WURIcmZxbW4?oc=5", "source_name": "FinancialContent", "published_at": "2026-07-23T00:44:00+00:00", "published_display": "23 Jul 2026 00:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomarker Collaboration and Licensing Deals Report 2016-2026 - Featuring Quanterix, Caris Life Sciences, Alnylam Pharmaceuticals, Guardant Health, Eurofins Scientific and More", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/biomarker-collaboration-licensing-deals-report-162800336.html", "source_name": "GlobeNewswire", "published_at": "2026-07-21T16:28:00+00:00", "published_display": "21 Jul 2026 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection (NASDAQ:CAI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPcmFJU0xwa0Q4QWFkQjN3NzgyR3pMRTV2UUhGOFBxUnRZMlc5TzB0dTBRZFhuVVV2T3VlTWEzUFRWbDR5SFE2TUl6bVZFc0hWOEVIZDBwR2d1YkRJcE9YY2R4c0dOSmdtVmdHbTRQX2tSUVVnbmdwanhid0tnellWazhQVmcybV9fRXVLYk14WERVcnRCWVVrWDZINUpJT0Fmc3BJblZoRjV2OE0wODBnSmJR?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-21T09:29:37+00:00", "published_display": "21 Jul 2026 09:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNd3VkT25zNzRGYVdWeXJCZC0xWXJCbXNyMjNUREdmOVBHeUk3WnZjaUNSRWpUVkxxcTBCWktmTl9CdmIxR1c3aUpJRkpHdGZMNUJOcllwckEyeTY4Y0V3dmNjSHc4NjlMNHd6ZlNobTJvdk9Ud1B6NFpZV3Z0Yl9ic0ZhY3c3dllMMkFaMHA5bGc1b1JGZFBReS1R?oc=5", "source_name": "Market source", "published_at": "2026-07-17T20:09:17+00:00", "published_display": "17 Jul 2026 20:09", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOS050VHA5bklaNkM1bWxTZTVyU3hjTmppd19Td0NDRHVIUXlGT1BEMkoxY0otTUJ3Ylo1N1pubDg2Z2R5U1oyb0Y1dEhEQVh4WTV5aTh1a3JNcG43RTZzVld1UUFBMjJPRUY4WEpYLWR0X2VqOUttSE4wMVoxNUJqYUpRSUlWZVFBbHV3S29aTVdGQVBSUVNZeg?oc=5", "source_name": "Market source", "published_at": "2026-07-17T14:10:31+00:00", "published_display": "17 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-17T12:35:12+00:00", "published_display": "17 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNQXZBYXdOMWxRNmRtU044Wk5ubUk0SzB5LW9RLW9zOW9Ob0h4dnFoRWpTd0oweTZMUXMwOG9keXdVZmExTWs3SHZPVjNFYzlQVS1GRE95QzRoUm01ZTlPbWtWa1Y2aFQ4SlIzMGk0YzhQTTlwdzhEelpKQThhd2pRX19KbmQ3WnJYYUdHT3pOSkMtTkw5S3ROVg?oc=5", "source_name": "Market source", "published_at": "2026-07-17T11:12:52+00:00", "published_display": "17 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-report-second-123000452.html", "source_name": "PR Newswire", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Sets 3:30 p.m. CT Webcast for Aug. 5", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOSXIyODN5YmgwSXg0OXFEY3NvYkUzYVdUUW5jc1gyWTlmTGtrdTBUSlBvODRicVJjU3djU3plSjR0V01PTlhab1F0RGppcklSejFfSWFIa1l2SGVteTlNV2hrX2p4T2FQazM5VDE3V3U3c1NTWEdMZmdxV1hwbkswckZGNXk5dUEwTWc5dUJPSUNaN1NHNTVta1dad01OSHl3NGhtTVgyR3hVMk8xRll5VXY4bmFTRGhlSGU0aGp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-16T12:30:00+00:00", "published_display": "16 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-expands-precision-123000480.html", "source_name": "PR Newswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences, Inc. (CAI) Receives a Buy from Bank of America Securities", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQZC16d2tuQ1ZrV2JvcHBwaE9SOUhmWnBKM3pKdTNLVnE4TTdrdTQ3RG9PY0lFLXJ4clFYMXVXZk1wYm0wdzl3QVNMMWJjNGNBUTc3dTRSdzFCd2hSckpZbDFOTGlFS2FWV0paTXltaExBemNwa0VCRF9vWVNacGFtWVdkYmE3MHNtTVJ4ZHEtRjVXWWZQUzdQelFmd0JLeXYwZWJDVkxCWENzMnA5OUo3QWtKaDZXUGpzV3hZWUJaTjdJbGpuV0RzdVlyRGVWVDBmU2xRU0lVZ2pWckNUbC1uQURZS0xaZ1FCTDd3RVQxaw?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-14T10:26:00+00:00", "published_display": "14 Jul 2026 10:26", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BofA Adjusts Price Target on Caris Life Sciences to $23 From $28", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/bofa-adjusts-price-target-caris-153602935.html", "source_name": "MT Newswires", "published_at": "2026-07-13T15:36:02+00:00", "published_display": "13 Jul 2026 15:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Caris Life Sciences, Inc. Insider Trading Activity", "summary": "Caris Life Sciences director Jon Halbert reported an open-market purchase of 68,000 shares of Common Stock on May 15, 2026, at a weighted average price of $14.56 per share. This transaction was conducted through LAH Investments, Ltd., increasing its indirect holdings to 704,598 s", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-a224c1601370.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:39:18", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Caris Life Sciences (NASDAQ:CAI) Director Acquires $990,080.00 in Stock", "summary": "Caris Life Sciences (NASDAQ:CAI) Director Jon Halbert purchased 68,000 shares of the company's stock for $990,080 on May 15th, increasing his total ownership to 704,598 shares. This insider buying comes as the company also announced a $100 million share repurchase program, sugges", "url": "https://www.marketbeat.com/instant-alerts/insider-buying-caris-life-sciences-nasdaqcai-director-acquires-99008000-in-stock-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T15:39:18", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Caris Life Sciences Inc For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Caris Life Sciences Inc., dated July 13. Form 4s disclose transactions made by company insiders, and are routinely published by Investing.com. The information provided is brief, stating only the company name and filing date.", "url": "https://ca.investing.com/news/stock-market-news/form-4-caris-life-sciences-inc-for-13-july-93CH-4730876", "source_name": "Investing.com Canada", "published_at": "2026-07-13T07:30:00", "published_display": "13 Jul 2026 07:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Recommendation of \"Hold\" from Brokerages", "summary": "Caris Life Sciences, Inc. (NASDAQ:CAI) has received a consensus \"Hold\" rating from eleven brokerages, with an average 12-month price target of $26.11. Insider activity shows Director Jeff L. Vacirca increasing his stake by 166.75%, and the company's board has authorized a $100 mi", "url": "https://www.marketbeat.com/instant-alerts/caris-life-sciences-inc-nasdaqcai-receives-consensus-recommendation-of-hold-from-brokerages-2026-07-10/", "source_name": "MarketBeat", "published_at": "2026-07-11T02:11:52", "published_display": "11 Jul 2026 02:11", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-cai-launches-135915925.html", "source_name": "Insider Monkey", "published_at": "2026-07-10T13:59:15+00:00", "published_display": "10 Jul 2026 13:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Breakeven Is Near for Caris Life Sciences, Inc. (NASDAQ:CAI)", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/caris-life-sciences-launches-caris-123000122.html", "source_name": "PR Newswire", "published_at": "2026-07-01T12:30:00+00:00", "published_display": "01 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQVnlONnc4bklGbTNMOUs0bVl4Um50VWNZeGtGLUplYmNwLUJkcWVWaExDbnpibHRPLW9UU1ZrM0tTN2xiTFd4M2xrMXdnX3E3eGZHZEt5S091QzBjUkMzamtoWks5cG53cDdzX0VHbTA2MlJuaDh6bkpIVWdXQVRYVWFWYkNsVW1xRTM0QlVJWGxTUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Caris Life Sciences Stock Could Be the Most Mispriced Oncology Platform Trading Right Now", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNWp1cldjeHVZUEVxeFFEUmpHVlFja245a2hGamlwWjktQUg3NWlGVWg2NHRfTDRYQ29iODZvZC1VQk1HUTMzdmRwVXhxb1lLZDhMT0JQSVh4N2lIUFZCb1YwdS1LWE9ESFgyYUpSc3BKWVFjamVGcUtZVFhDM0xtRkxPV3JNUmlqbHdQNFlDbVlWX1F1aHlmcl9waG93blpvNDhNWDFKRldEN1ZJa2p4bnoyRzR3MG5VQWdN?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOYThaOGdncWV5VHB1QXQzMGVtU1ZjQkdzQnhhZVlCbDFHbnYzX215SkdBREdLNm5mUW9KYUc5dldhcWlLY2llQ1l6OFkzTHU1aHNDRXhhSGU0MkR1MFBHQ0ttdnhyN2RmTWhLNFViNmM5Z2hfc1NSa3ZGWkFTODloMHBjLVVJZU55cEJDOENsdUVkZUdiaGpF?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Announces $100M Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUFRBRG42V1l6djNYTEgwSTNYSURSU2w0MFItRS1sdzNxMGEyOXktbWZJdWtGZDRBa28yR05YTkk3MW1jRkdOSHdGUnBwS2ZQcXp6OFFsaEdydHlMMnRLSGZDaXp5RHNLY3lFYU9WY0NvR3FmMi1uM2hmNzdrRF9sckl6bnpCSEEtTlNwYy1IYWJodndMVDZjZ1Njdnl4LXc?oc=5", "source_name": "Market source", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Announces Dual Listing on NYSE Texas", "summary": "Caris Life Sciences (NASDAQ: CAI) announced a dual listing of its common stock on NYSE Texas, effective June 17, 2026. This move expands its presence in public markets while retaining its primary listing on NASDAQ. The dual listing is intended to provide additional exposure to in", "url": "https://www.morningstar.com/news/pr-newswire/20260616da84386/caris-life-sciences-announces-dual-listing-on-nyse-texas", "source_name": "Morningstar", "published_at": "2026-06-17T05:10:47", "published_display": "17 Jun 2026 05:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AI precision-medicine company Caris adds NYSE Texas listing", "summary": "Caris Life Sciences, a patient-centric AI TechBio and precision medicine company, announced a dual listing of its common stock on NYSE Texas, effective June 17, 2026. Shares will continue to trade on NASDAQ under the CAI ticker while also listing on NYSE Texas, aiming for increas", "url": "https://www.stocktitan.net/news/CAI/caris-life-sciences-announces-dual-listing-on-nyse-apdm69r81q7b.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:39:59", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Stock\u2019s Gross Margin Story: From 38% to 65% in Seven Quarters and What Comes Next", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPYzA2RlZNME5lVFRCSVBiT2RLaW85NnJkc0N0Tk1DZjhmNXVKdGIwRnhXVklmdExQZXIxNjJnY3FlR0QzTEhNa2FJSnN2azJ2OFBST1VoSlBFT1VLQV9TSDk3eW1xY1Q1ZEQ1ejQxWEZROUZLT1RGMnZwOXhTSmRjb21jQ04taUZfWjR0UmhRc0JhWnZBb3RNSDNYeVNaZS1MUGxWZDllWWtlQy1ucUxEMExFUWRDR28taG93bnBQN1I?oc=5", "source_name": "TIKR.com", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Announces Share Repurchase Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUW9LYWNXU3MzMDNyU0tTaEhmWWc4RHJCZFZiN0x6aGpkamZvbDRWTVlUTXVUZE1BS0pyaEY3ZDBtR3pwQ01jUFhwOHpZMU5RM25LQVJmOTJ4OWN0bFB3S0dIS2dUd2g1OEJjcy1PbGQ4Ri1oMm00eTJtYlpqczVXUzRRUWswRUFibTZDZEZQM1FEVHpZclJTZWNFei1tQmxZTF9CenZRRnMwLXdFbXZF?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director takes Caris Life Sciences (CAI) 2026 board fees in stock", "summary": "Caris Life Sciences director Jonathan Kenneth Charles Knowles received 1,600 shares of common stock on May 29, 2026, as compensation for his 2026 board retainer fees. These shares were granted in lieu of cash, based on a ten-day volume weighted average price calculation of $15.62", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-3865b8a3748a.html", "source_name": "Stock Titan", "published_at": "2026-06-02T22:40:55", "published_display": "02 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing", "summary": "Caris Life Sciences has launched its \"Behind the Diagnosis\" campaign to highlight how its comprehensive genomic testing and AI-powered precision medicine have transformed patient care. The inaugural story features Erika Rios, whose initial diagnosis of stage 4 metastatic breast c", "url": "https://www.biospace.com/press-releases/caris-life-sciences-launches-behind-the-diagnosis-campaign-spotlighting-patient-lives-transformed-by-caris-comprehensive-genomic-testing", "source_name": "BioSpace", "published_at": "2026-06-01T22:09:36", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life (CAI) director granted 1,600 shares for 2026 board fees", "summary": "Caris Life Sciences director George Poste received 1,600 shares of common stock as compensation for his 2026 board retainer fees, granted at a reference price of $15.62 per share. This equity award, given in lieu of cash, brings his direct holdings to 17,729 shares. Additionally,", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-12d5f62338dd.html", "source_name": "Stock Titan", "published_at": "2026-05-31T17:39:45", "published_display": "31 May 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CAI - Caris Life Sciences Inc Stock Price and Quote", "summary": "This article provides a detailed stock quote and financial data for Caris Life Sciences Inc. (CAI), including its latest closing price, market capitalization, key financial ratios, and analyst ratings. It also lists recent news announcements and insider trading activities related", "url": "https://finviz.com/stock?t=CAI", "source_name": "Finviz", "published_at": "2026-05-30T09:39:28", "published_display": "30 May 2026 09:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "You\u2019ve Likely Never Heard of Caris Life Sciences Stock. Billionaire Stanley Druckenmiller Has \u2013 and He Likes What He Sees.", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQQWNpSkY3NFFkbWRXdS1EWDJFX1BVemM5YjU2SUhQRXZtbTduLWZyNF9HNThvUXc2ZzQ5b3JTYzBLQWlqMnVYY0cyS2x1S3ItRHJ0alVXdzl0ek9LSzVURjllZlVFeUViUDFBLVVfeHpLcEJuMnVGbnNkWHBtbDcwbl9TMzFpb3NHbjRwQ2RJR05JRnNsR09r?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence", "summary": "Caris Life Sciences, along with the Caris Precision Oncology Alliance and over 60 collaborators, will present 32 studies at the 2026 ASCO Annual Meeting. These studies focus on multi-omic biomarker research and real-world data to enhance understanding of tumor biology and guide p", "url": "https://www.morningstar.com/news/pr-newswire/20260522da65612/caris-life-sciences-to-present-32-studies-at-asco-2026-highlighting-advances-in-multi-omic-biomarker-research-and-real-world-evidence", "source_name": "Morningstar", "published_at": "2026-05-20T05:09:10", "published_display": "20 May 2026 05:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) exec has 6,047 shares withheld for RSU taxes", "summary": "Caris Life Sciences executive John Russel Denton had 6,047 shares of common stock withheld at $15.25 per share to cover RSU taxes on May 15, 2026. This transaction is categorized as a non-market tax-withholding disposition, not an open-market sale. Following this activity, Denton", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-b9ca07940683.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) logs RSU tax share withholding", "summary": "Caris Life Sciences president David Baxley Spetzler reported a routine tax-withholding disposition for 13,856 shares of common stock at $15.25 per share, covering taxes related to vested Restricted Stock Units (RSUs). Following this transaction, Spetzler directly owns 530,083 sha", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-0c8a048c9191.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) director logs RSU tax withholding and large indirect stake", "summary": "Caris Life Sciences director David D. Halbert reported a routine disposition of 40,712 shares of Common Stock to cover tax obligations related to the vesting of restricted stock units (RSUs) at a price of $15.25 per share. After this transaction, Mr. Halbert directly holds 2,574,", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-6b3b29b324c8.html", "source_name": "Stock Titan", "published_at": "2026-05-19T04:40:00", "published_display": "19 May 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%", "summary": "Caris Life Sciences is expanding its precision oncology platform, product pipeline, and biopharma partnerships after its IPO last June, seeing significant growth potential in the oncology market, which is currently only about 35% penetrated. The company reported a 79% year-over-y", "url": "https://www.marketbeat.com/instant-alerts/caris-life-sciences-eyes-bigger-oncology-market-after-ipo-as-revenue-jumps-79-2026-05-13/", "source_name": "MarketBeat", "published_at": "2026-05-17T20:10:29", "published_display": "17 May 2026 20:10", "sentiment": "positive", "sentiment_pct": 93, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Druckenmiller's Duquesne Office Invests in Broadcom and Caris Life Sciences", "summary": "Duquesne Family Office, led by Stanley Druckenmiller, made significant investment shifts in Q1 2026, acquiring shares in Broadcom (AVGO) and Caris Life Sciences (CAI) while exiting positions in Alphabet Class A and Cogent Biosciences. The firm also increased its holdings in STMic", "url": "https://intellectia.ai/news/stock/druckenmillers-duquesne-office-invests-in-broadcom-and-caris-life-sciences", "source_name": "Intellectia AI", "published_at": "2026-05-15T21:09:28", "published_display": "15 May 2026 21:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)", "summary": "Two healthcare stocks, Crispr Therapeutics AG (CRSP) and Caris Life Sciences, Inc. (CAI), have received bullish sentiments from analysts. Crispr Therapeutics AG was maintained with a Buy rating and an $83 price target by Bank of America Securities, with a Moderate Buy consensus a", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CRSP-Q/pressreleases/1951199/analysts-are-bullish-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-caris-life-sciences-inc-cai/", "source_name": "The Globe and Mail", "published_at": "2026-05-15T08:08:47", "published_display": "15 May 2026 08:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Caris Life Sciences Q1 2026 sees robust growth but stock dips", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxPWkNMeVpkTk40eU1IQUpWWXA3V3cwc2JpNUlKLUVfUngzMWpOeVpDQ2ZtMkdHVEZ3ZHh1V20zU1paX19hRHJhSXdCUEV3aTM2SVE5VTR6QTIzTTR2TThyNVZpZzRXMEgzbU02RUlHVUotSExodTRQbnlLZGl0U1lHcDFQWExNeWVNd1dEQ3B4dUxZTHJZNDcxSk9RUll3d2F2c2dMMFhJOVhXMzE1blBHUjJuUUxrbW5qMEVsV2tRS09HY3E0MkJwX2JBUzNXUndGLTByWG5PQk9FZw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Caris Life Sciences (CAI) Valuation After Recent Growth, Product Launches And Clinical Data Advances", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G/A] Caris Life Sciences, Inc. Amended Passive Investment Disclosure", "summary": "TSSP Sub-Fund HoldCo, LLC and Alan Waxman have jointly filed an amended Schedule 13G/A, disclosing their beneficial ownership stakes in CARIS Life Sciences, Inc. As of March 31, 2026, TSSP Sub-Fund HoldCo holds 4.8% of outstanding common stock, while Alan Waxman holds 5.1%, both ", "url": "https://www.stocktitan.net/sec-filings/CAI/schedule-13g-a-caris-life-sciences-inc-amended-passive-investment-dis-bb1351896ef5.html", "source_name": "Stock Titan", "published_at": "2026-05-12T21:39:43", "published_display": "12 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "J.H. Whitney reports 18.26M shares of Caris Life Sciences (CAI)", "summary": "J.H. Whitney VI, L.P. and its affiliated reporting persons have disclosed a beneficial ownership of 18,256,615 shares of Caris Life Sciences, Inc. (CAI) common stock, which represents 6.5% of the class. This information was reported in an amended Schedule 13G filing. The reportin", "url": "https://www.stocktitan.net/sec-filings/CAI/schedule-13g-a-caris-life-sciences-inc-amended-passive-investment-dis-c8c3cbaae8e0.html", "source_name": "Stock Titan", "published_at": "2026-05-12T14:39:43", "published_display": "12 May 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director buys 31K Caris Life Sciences (CAI) shares around $16.15", "summary": "Caris Life Sciences director Jeff L. Vacirca purchased 31,050 shares of Common Stock in an open-market transaction at a weighted average price of $16.149 per share. This purchase increased his direct ownership to 49,671 shares. The transaction is viewed positively and was reporte", "url": "https://www.stocktitan.net/sec-filings/CAI/form-4-caris-life-sciences-inc-insider-trading-activity-95e3dcb195b4.html", "source_name": "Stock Titan", "published_at": "2026-05-12T12:32:41", "published_display": "12 May 2026 12:32", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences (CAI) Turns Q4 Profit After US$517 Million Quarterly Loss Testing Bullish Thesis", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging revenue lifts Caris Life Sciences (CAI) toward profit in Q1 2026", "summary": "Caris Life Sciences (CAI) reported strong Q1 2026 growth, with total revenue nearly doubling to $216.174 million, primarily driven by molecular profiling services. The company achieved income from operations of $5.282 million and narrowed its net loss to $0.510 million, indicatin", "url": "https://www.stocktitan.net/sec-filings/CAI/10-q-caris-life-sciences-inc-quarterly-earnings-report-1c89c6ad3f63.html", "source_name": "Stock Titan", "published_at": "2026-05-08T20:09:42", "published_display": "08 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood\u2011Based Testing Authorization", "summary": "Caris Life Sciences has submitted an application to the New York State Department of Health (NYSDOH) for authorization of its Caris Assure blood-based molecular profiling test. This test, which analyzes whole exome and transcriptome, is designed to support comprehensive biomarker", "url": "https://www.morningstar.com/news/pr-newswire/20260508da55078/caris-life-sciences-submits-application-to-new-york-state-department-of-health-for-caris-assure-bloodbased-testing-authorization", "source_name": "Morningstar", "published_at": "2026-05-08T20:05:00", "published_display": "08 May 2026 20:05", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Caris Life Sciences (CAI) Valuation As Shares Trade Below Narrative Fair Value", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONWV6MzBudExCa2RRdkFxTUFoeDdLUXRDZUdYMXRYSE1CNFBqS0d5TVQ0VmZOWkpMZFRjTVFhN3pTT195OUVrcEhmaEVBVGN6Y2E0dUF6WE15b295S19lV3FQVGFSOEJrRFpsTzdkcjhqVGNIN2dJdGd5VUpkbzYwaUxaV1RKVjEzcEx4cnFXSkZuTXhubC1vbktWeHh3ekU?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Time To Reconsider Caris Life Sciences (CAI) After 26.5% Year To Date Decline?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caris Life Sciences Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNMHRLNkhFTk9FcGtHMG9lM0ZIT1RoWkpVN2o5cVBBNXREYmNiQUxwSDUyV3BGS3l1OTZaMFlvOUxRdDA3b291SmFMVnhNSjN5QlZ3ODFYN1UtZGpQYjBETnZJUW1qVTVoaUZFUEdQdWJ3TGpPRnB6dlhlMmJOc3N5Q1ZfWDBoV1JxQThQMVZYc2lfbzN5eHlEV0FVRXNGT2xaVnZwRXBlY2ptYThvNTB4U2JDa25tUzFYMk10Mg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 106, "total_relevant": 77, "sentiment_summary": {"positive": 26, "negative": 4, "neutral": 47, "score": 57, "total": 77, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 25.95, "count": 44}, {"event": "earnings", "label": "Earnings", "weight": 10.8, "count": 21}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "capital_return", "label": "Capital return", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 26, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 16.49, "latest_week": "2026-07-17", "one_week_move": -2.9, "four_week_move": -10.7, "twelve_week_move": -18.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.370689, "market_dynamics_buy_signal": false, "relative_strength": -40.131669, "fair_value_gap": -33.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.5136, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.9% over one week, -10.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 14}, {"label": "Stock Titan", "count": 12}, {"label": "simplywall.st", "count": 7}, {"label": "PR Newswire", "count": 5}, {"label": "MarketBeat", "count": 3}, {"label": "Morningstar", "count": 3}, {"label": "The Globe and Mail", "count": 2}, {"label": "TIKR.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 69}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 44}, {"label": "Earnings", "count": 21}, {"label": "Analyst action", "count": 5}, {"label": "Capital return", "count": 3}, {"label": "Balance sheet", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "69", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.9% over one week, -10.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Caris Life Sciences, Inc. - Common Stock (CAI) Stock Price, News, Quote & History"}], "updated_at": "2026-07-23T10:28:43.146037+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}